We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Top Sells

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$11.2M
2
BAP icon
Credicorp
BAP
+$9.17M
3
NXT icon
Nextpower Inc. Common Stock
NXT
+$6.93M
4
XP icon
XP
XP
+$6.54M
5
STRL icon
Sterling Infrastructure
STRL
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVT icon
301
Avnet
AVT
$7.64B
$220K 0.03%
2,477
– –
DECK icon
302
Deckers Outdoor
DECK
$10.9B
$218K 0.03%
2,197
– –
CTO
303
CTO Realty Growth
CTO
$765M
$212K 0.03%
+9,847
New +$199K
NESR
304
National Energy Services Reunited Corp
NESR
$3.28B
$211K 0.03%
7,049
– –
TER icon
305
Teradyne
TER
$55.2B
$210K 0.03%
+433
New +$163K
CROX icon
306
Crocs
CROX
$5.9B
$209K 0.03%
1,731
– –
PRAA icon
307
PRA Group
PRAA
$774M
$208K 0.03%
+10,967
New +$195K
EWBC icon
308
East-West Bancorp
EWBC
$17.2B
$207K 0.03%
1,600
– –
SPNT icon
309
SiriusPoint
SPNT
$2.84B
$206K 0.03%
8,567
– –
PODD icon
310
Insulet
PODD
$9.82B
$203K 0.03%
1,333
+833
+167% +$139K
FIVN icon
311
FIVE9
FIVN
$2.58B
$199K 0.03%
+9,314
New +$184K
PK icon
312
Park Hotels & Resorts
PK
$3.03B
$199K 0.03%
13,934
– –
PAYS icon
313
Paysign
PAYS
$701M
$191K 0.02%
+23,347
New +$155K
QNST icon
314
QuinStreet
QNST
$1.01B
$188K 0.02%
12,834
-38,153
-75% -$479K
FFIV icon
315
F5
FFIV
$24.6B
$184K 0.02%
+443
New +$157K
EW icon
316
Edwards Lifesciences
EW
$50.9B
$182K 0.02%
2,015
– –
AOSL icon
317
Alpha and Omega Semiconductor
AOSL
$763M
$182K 0.02%
+3,845
New +$154K
FMAO icon
318
Farmers & Merchants Bancorp
FMAO
$491M
$181K 0.02%
5,931
– –
SBFG icon
319
SB Financial Group
SBFG
$184M
$179K 0.02%
7,085
– –
TBPH icon
320
Theravance Biopharma
TBPH
$885M
$179K 0.02%
10,512
– –
OSCR icon
321
Oscar Health
OSCR
$9.87B
$178K 0.02%
+6,245
New +$134K
LQDA icon
322
Liquidia Corp
LQDA
$6.12B
$175K 0.02%
+2,191
New +$117K
OBT icon
323
Orange County Bancorp
OBT
$512M
$173K 0.02%
4,714
– –
PAGS icon
324
PagSeguro Digital
PAGS
$2.64B
$173K 0.02%
19,148
– –
RNGR icon
325
Ranger Energy Services
RNGR
$386M
$173K 0.02%
10,792
– –
11 12
13
14 15

Similar funds

CC
Converium Capital Montreal $783M AUM
CCG
Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $783M AUM 19.25% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CWP
CFM Wealth Partners Austin, Texas $783M AUM 47.07% 1-Year Est. Return

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.